We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

11 hedge funds and large institutions have $241K invested in Catheter Precision in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10% more funds holding

Funds holding: 10 → 11 (+1)

0% less ownership

Funds ownership: 0.04% → 0.04% (-0%)

37% less capital invested

Capital invested by funds: $383K → $241K (-$142K)

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$60.1K
2
VF
Virtu Financial
New York
+$15K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.99K
4
TSS
Two Sigma Securities
New York
+$9.76K
5
TRCT
Tower Research Capital (TRC)
New York
+$1.51K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$16.1K
2
Renaissance Technologies
Renaissance Technologies
New York
-$8.02K
3
UBS Group
UBS Group
Switzerland
-$2.76K
4
Bank of America
Bank of America
North Carolina
-$85
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$137K +$60.1K +517 +47%
Baird Financial Group
2
Baird Financial Group
Wisconsin
$44.7K – – –
VF
3
Virtu Financial
New York
$17K +$15K +129 +193%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$13.1K +$9.99K +86 +125%
Renaissance Technologies
5
Renaissance Technologies
New York
$10K -$8.02K -69 -36%
BlackRock
6
BlackRock
New York
$8.19K – – –
TSS
7
Two Sigma Securities
New York
$7.09K +$9.76K +84 New
TRCT
8
Tower Research Capital (TRC)
New York
$3.35K +$1.51K +13 +48%
HI
9
Harbour Investments
Wisconsin
$675 +$929 +8 New
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Quebec, Canada
$89 – – –
APC
11
Aspire Private Capital
North Carolina
$53 +$116 +1 New
Wells Fargo
12
Wells Fargo
California
$19 – – –
Qube Research & Technologies (QRT)
13
Qube Research & Technologies (QRT)
United Kingdom
$3 – – –
KFI
14
Key Financial Inc
Pennsylvania
$1 – – –
Citadel Advisors
15
Citadel Advisors
Florida
– -$16.1K -92 Closed
UBS Group
16
UBS Group
Switzerland
– -$2.76K -16 Closed
Bank of America
17
Bank of America
North Carolina
– -$85 – –

VTAK Hedge Fund Activity: Q3 2023 in Review

11 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q3 2023, worth a combined $241K — down 37% from $383K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VTAK positions and 2 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $60.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $16.1K sold.

  • 11 institutional investors held Catheter Precision (VTAK) as of Q3 2023, up from 10 in Q2 2023.
  • Funds reported $241K of Catheter Precision stock for Q3 2023, down 37% quarter-over-quarter.
  • 3 funds opened new Catheter Precision positions in Q3 2023 and 2 closed out, a net change of +1 holder.
  • The largest Catheter Precision buyer in Q3 2023 was Armistice Capital, an estimated $60.1K added.
  • The largest Catheter Precision seller in Q3 2023 was Citadel Advisors, an estimated $16.1K sold.

Based on aggregated 13F filings for Q3 2023.